Robert H. Vonderheide

Also affiliated with Sidney Kimmel Cancer Center, Parker Institute for Cancer Immunotherapy, UPMC Hillman Cancer Center, Abramson Cancer Center, University of Pennsylvania

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

3.5Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The Cancer Surfaceome Atlas integrates genomic, functional and drug response data to identify actionable targets

Nature Cancer(2021)10.1038/s43018-021-00282-w

Top 6%

3.5DataRank

Top 6%150 citations

Jiao Yuan, Meixiao Long, Junjie Jiang, Youyou Zhang, Tianli Zhang +10 more

Papers

Driven by 49 papers — median percentile 94. Top paper: “Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer”.

Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer

Nature(2024)10.1038/s41586-024-07379-z

N/A

3.9DataRank · unranked

182 citations

Jingjing Jiang, Tanner C. Dalton, Álvaro Curiel‐García, A. Cole Edwards, Yingyun Wang +61 more

The Cancer Surfaceome Atlas integrates genomic, functional and drug response data to identify actionable targets

Nature Cancer(2021)10.1038/s43018-021-00282-w

Top 6%

3.5DataRank

Top 6%150 citations

Jiao Yuan, Meixiao Long, Junjie Jiang, Youyou Zhang, Tianli Zhang +10 more

Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma

Cancer Research Communications(2023)10.1158/2767-9764.crc-22-0486

N/A

2.2DataRank · unranked

95 citations

Alexander C. Huang, Xiaowei Xu, Robert Orlowski, Ravi K. Amaravadi, Lynn M. Schuchter +20 more

Challenges and Opportunities for Pancreatic Cancer Immunotherapy

Cancer Cell(2020)10.1016/j.ccell.2020.08.004

N/A

0.971DataRank · unranked

645 citations

Robert H. Vonderheide, Mark H. O’Hara, Adham S. Bear

Natural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumors

Journal of Clinical Investigation(2024)10.1172/jci175790

N/A

0.794DataRank · unranked

28 citations

Rebecca B. Nadler, Mark H. O’Hara, Kelsey Stanton, Chong Xu, Robert Saporito +14 more

Machine Learning Links T-cell Function and Spatial Localization to Neoadjuvant Immunotherapy and Clinical Outcome in Pancreatic Cancer

Cancer Immunology Research(2024)10.1158/2326-6066.cir-23-0873

N/A

0.718DataRank · unranked

28 citations

Shamilene Sivagnanam, Courtney B. Betts, Konjit Betre, Nell Kirchberger, Benjamin J. Tate +9 more

Pivotal roles for cancer cell–intrinsic mPGES-1 and autocrine EP4 signaling in suppressing antitumor immunity

JCI Insight(2024)10.1172/jci.insight.178644

N/A

0.399DataRank · unranked

9 citations

Il‐Kyu Kim, Charu Arora, Liz Quinones-Ware, Nikhil Joshi, Noah Cheng +12 more

SARS-CoV-2 Seropositivity and Seroconversion in Patients Undergoing Active Cancer-Directed Therapy

JCO Oncology Practice(2021)10.1200/op.21.00113

N/A

0.373DataRank · unranked

3 citations

Sanjna Surya, Noah G. Goodman, Anh N. Le, Gregory Kelly, Olutosin Owoyemi +37 more

SARS-CoV-2 seropositivity and seroconversion in patients undergoing active cancer-directed therapy

medRxiv(2021)10.1101/2021.01.15.21249810

N/A

0.104DataRank · unranked

1 citations

Sanjna Surya, Noah Goodman, Anh N. Le, Greg Kelly, Olutosin Owoyemi +37 more

Rates of COVID-19-related Outcomes in Cancer compared to non-Cancer Patients

medRxiv(2020)10.1101/2020.08.14.20174961

N/A

0DataRank · unranked

16 citations

Sanjna Surya, Anh N. Le, Heena Desai, Abigail Doucette, Peter Gabriel +11 more

Peripheral blood immune correlates associated with TGF-β inhibition (galunisertib) and stereotactic body radiotherapy (SBRT) in patients with advanced hepatocellular carcinoma (HCC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4575

N/A

0DataRank · unranked

0 citations

Kim Anna Reiss, Michael A. Giannone, Nevena Damjanov, Elizabeth Prechtel Dunphy, Lisa Dicicco +8 more

CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer

Nature Medicine(2021)10.1038/s41591-021-01386-7

N/A

0DataRank · unranked

520 citations

Nicholas Han, Paul Wileyto, Justin Kim, Sigrid Gouma, James Robinson +55 more

Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1047

N/A

0DataRank · unranked

183 citations

Courtney B. Betts, Rosemarie Mick, Shamilene Sivagnanam, David L. Bajor, Daniel A. Laheru +24 more

Leukocyte Heterogeneity in Pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with Clinical Outcome

Cancer Discovery(2021)10.1158/2159-8290.cd-20-0841

N/A

0DataRank · unranked

162 citations

Courtney B. Betts, Shamilene Sivagnanam, Vicente Morales‐Oyarvide, Annacarolina da Silva, Chen Yuan +25 more

Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40

Nature Communications(2021)10.1038/s41467-021-23832-3

N/A

0DataRank · unranked

152 citations

Zhenqiang He, Hao Duan, Duo Zhang, Juehui Li, Huijuan Yang +13 more

Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting

Nature Communications(2021)10.1038/s41467-021-24562-2

N/A

0DataRank · unranked

112 citations

Tatiana Blanchard, Joseph Cesare, Michael Ford, Lee P. Richman, Chong Xu +14 more

Site-Dependent Immune Escape Due to Impaired Dendritic Cell Cross-Priming

Cancer Immunology Research(2021)10.1158/2326-6066.cir-20-0785

N/A

0DataRank · unranked

28 citations

Jeffrey Lin, Robert H. Vonderheide, Mark S. Diamond

Vitamin D deficiency after allogeneic hematopoietic cell transplantation promotes T-cell activation and is inversely associated with an EZH2-ID3 signature

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.09.017

N/A

0DataRank · unranked

4 citations

Chloé Pasin, Alex Ganetsky, David W Harle, Ximi K. Wang, Kirubel Belay +9 more

A unique window of opportunity for practical reform of cancer clinical trials

Cancer(2021)10.1002/cncr.33585

N/A

0DataRank · unranked

3 citations

Vicki Sallée, M. Hendricks, Colleen Redlinger Tabery, Meghan L. Blair, Erica Dahlmeier +4 more

Accrual of Black participants to cancer clinical trials following a five-year prospective initiative of community outreach and engagement.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.100

N/A

0DataRank · unranked

12 citations

Vicki Sallée, Wei‐Ting Hwang, Brenda L. Bryant, Armenta L. Washington, Samuel U Takvorian +6 more

Final results of a phase I “RadVax” trial of hypofractionated radiation combined with pembrolizumab in patients with metastatic solid tumors.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2576

N/A

0DataRank · unranked

4 citations

Rosemarie Mick, Alexander C. Huang, Nicholas Han, Michael D. Farwell, Tara C. Mitchell +11 more

Baseline level and early on-treatment clearance of circulating mutant KRAS in metastatic pancreatic ductal adenocarcinoma treated with chemotherapy with or without immunotherapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4122

N/A

0DataRank · unranked

1 citations

Aseel Abdalla, Neha Bhagwat, Taylor A. Black, Zhuoyang Wang, Stephanie S. Yee +15 more

Genetic and immune divergence in pancreatic cancer lesions at the time of metastatic relapse compared to primary tumor.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4140

N/A

0DataRank · unranked

0 citations

Derek A. Oldridge, Emma E. Furth, Michael D. Feldman, Andrew J. Rech, Robert H. Vonderheide +1 more

An open protocol for modeling T Cell Clonotype repertoires using TCRβ CDR3 sequences

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.30.486449

N/A

0DataRank · unranked

0 citations

Wesley Horton, Dhaarini Murugan, Biqing Zhu, Patrick Leyshock, Sushil Kumar +8 more

T cell immune deficiency rather than chromosome instability predisposes patients with short telomere syndromes to squamous cancers

Cancer Cell(2023)10.1016/j.ccell.2023.03.005

N/A

0DataRank · unranked

68 citations

Diane A. Flasch, Christine C. Atik, Zoe L. Cosner, Amanda L. Blackford, Wentao Yang +9 more

Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.03.569791

N/A

0DataRank · unranked

11 citations

Jingjing Jiang, Alvaro Curiel-Garcia, Yingyun Wang, Bianca J. Lee, Margo Orlen +42 more

Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy

Research Square(2023)10.21203/rs.3.rs-2960521/v1

N/A

0DataRank · unranked

3 citations

Mark S. Diamond, Salina Yuan, Samantha B. Kemp, Qinglan Li, Jeffrey H. Lin +10 more

Machine learning links T cell function and spatial localization to neoadjuvant immunotherapy and clinical outcome in pancreatic cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.20.563335

N/A

0DataRank · unranked

1 citations

Shamilene Sivagnanam, Courtney B. Betts, Konjit Betre, Nell Kirchberger, Benjamin J. Tate +9 more

An open protocol for modeling T Cell Clonotype repertoires using TCRβ CDR3 sequences

Research Square(2023)10.21203/rs.3.rs-2140339/v1

N/A

0DataRank · unranked

0 citations

Wesley Horton, Dhaarini Murugan, Biqing Zhu, Patrick Leyshock, Sushil Kumar +8 more

Data from Targeting HER-2/neu in Early Breast Cancer Development Using Dendritic Cells with Staged Interleukin-12 Burst Secretion

(2023)10.1158/0008-5472.c.6496416

N/A

0DataRank · unranked

0 citations

Gary K. Koski, Ursula Koldovsky, Shuwen Xu, Peter A. Cohen, Rosemarie Mick +16 more

Data from Functional Unresponsiveness and Replicative Senescence of Myeloid Leukemia Antigen–specific CD8+ T Cells After Allogeneic Stem Cell Transplantation

(2023)10.1158/1078-0432.c.6518094

N/A

0DataRank · unranked

0 citations

Jasmine S. Smith, Ran Reshef, Kunal P. Patel, Theresa A. Colligon, Barbara A. Vance +5 more

Data from Rapid Immune Recovery and Graft-versus-Host Disease–like Engraftment Syndrome following Adoptive Transfer of Costimulated Autologous T Cells

(2023)10.1158/1078-0432.c.6517645.v1

N/A

0DataRank · unranked

0 citations

Edward A. Stadtmauer, Nicole A. Aqui, Dan T. Vogl, Anne Chew, Hong‐Bin Fang +20 more

Data from Functional Unresponsiveness and Replicative Senescence of Myeloid Leukemia Antigen–specific CD8+ T Cells After Allogeneic Stem Cell Transplantation

(2023)10.1158/1078-0432.c.6518094.v1

N/A

0DataRank · unranked

0 citations

Jasmine S. Smith, Ran Reshef, Kunal P. Patel, Theresa A. Colligon, Barbara A. Vance +5 more

Data from Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T cells Administered Intravenously in Patients with Melanoma & Breast Carcinoma

(2023)10.1158/2767-9764.c.6547846.v1

N/A

0DataRank · unranked

0 citations

Alexander C. Huang, Xiaowei Xu, Robert Orlowski, Ravi K. Amaravadi, Lynn M. Schuchter +20 more

Data from CD4+ T Lymphocyte Ablation Prevents Pancreatic Carcinogenesis in Mice

(2023)10.1158/2326-6066.c.6548512.v1

N/A

0DataRank · unranked

0 citations

Wei Yan, Esha Mathew, Filip Bednar, Shanshan Wan, Meredith A. Collins +5 more

Data from Site-Dependent Immune Escape Due to Impaired Dendritic Cell Cross-Priming

(2023)10.1158/2326-6066.c.6550629.v1

N/A

0DataRank · unranked

0 citations

Jeffrey Lin, Robert H. Vonderheide, Mark S. Diamond

Data from Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma

(2023)10.1158/2767-9764.c.6547846.v2

N/A

0DataRank · unranked

0 citations

Alexander C. Huang, Xiaowei Xu, Robert Orlowski, Ravi K. Amaravadi, Lynn M. Schuchter +20 more

The COVID-19 pandemic's impact on diagnosis of cancers detectable through screening.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e18669

N/A

0DataRank · unranked

0 citations

Peter Gabriel, Abigail Doucette, C. Grosso, Armenta L. Washington, Emily Verderame +15 more

Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy in pancreatic ductal adenocarcinoma

Nature Communications(2024)10.1038/s41467-024-46048-7

N/A

0DataRank · unranked

28 citations

Mark S. Diamond, Salina Yuan, Samantha B. Kemp, Benjamin Kahn, Qinglan Li +12 more

Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma

Nature Communications(2024)10.1038/s41467-024-49915-5

N/A

0DataRank · unranked

13 citations

Lee McDaniel, Changgee Chang, Qi Long, Shannon M. Pfeiffer, Jaclyn P. Lyman +37 more

Impact of pandemic on accrual of minority participants to interventional cancer clinical trials.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e18581

N/A

0DataRank · unranked

0 citations

Vicki Sallée, Peter Gabriel, Abigail Doucette, Wallace P Wormley, Colleen M. Grosso +7 more

Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis

The Journal of Experimental Medicine(2020)10.1084/jem.20190673

N/A

0DataRank · unranked

177 citations

Austin P. Huffman, Max M. Wattenberg, David M. Walter, Erica L. Carpenter, David M. Feldser +4 more

Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3978

N/A

0DataRank · unranked

152 citations

Todd S. Crocenzi, Jennifer N. Durham, Elizabeth A. Sugar, Annie A. Wu, Beth Onners +16 more

Sufficiency of CD40 activation and immune checkpoint blockade for T cell priming and tumor immunity

Proceedings of the National Academy of Sciences(2020)10.1073/pnas.1918971117

N/A

0DataRank · unranked

142 citations

Mark S. Diamond, Ceire Hay, Katelyn T. Byrne, Robert H. Vonderheide, Alexander H. Morrison

Epigenetic and Transcriptional Control of the Epidermal Growth Factor Receptor Regulates the Tumor Immune Microenvironment in Pancreatic Cancer

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0519

N/A

0DataRank · unranked

136 citations

Salina Yuan, Robert J. Norgard, Fangxue Yan, Yu Sun, Il‐Kyu Kim +9 more

Tumor-Derived Myeloid Cell Chemoattractants and T Cell Exclusion in Pancreatic Cancer

Frontiers in Immunology(2020)10.3389/fimmu.2020.605619

N/A

0DataRank · unranked

45 citations

Adham S. Bear, Robert H. Vonderheide

A Pilot Study of Galunisertib plus Stereotactic Body Radiotherapy in Patients with Advanced Hepatocellular Carcinoma

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-20-0632

N/A

0DataRank · unranked

19 citations

Max M. Wattenberg, Nevena Damjanov, Elizabeth Prechtel Dunphy, Mona Jacobs-Small, Maryanne J. Lubas +12 more

Rates of COVID-19–Related Outcomes in Cancer Compared With Noncancer Patients

JNCI Cancer Spectrum(2020)10.1093/jncics/pkaa120

N/A

0DataRank · unranked

45 citations

Sanjna Surya, Anh N. Le, Heena Desai, Abigail Doucette, Peter Gabriel +11 more

Phase I trial of autologous cMET-directed CAR-t cells administered intravenously in patients with melanoma & breast carcinoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10035

N/A

0DataRank · unranked

22 citations

Alexander C. Huang, Xiaowei Xu, Paul J. Zhang, Robert Orlowski, Tina Matlawski +15 more

Robert H. Vonderheide

Indexed papers

Top data-sharing exemplar

Papers